Insider Trading Activity - Forbion Capital Fund IV Cooperatief U.A.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Forbion Capital Fund IV Cooperatief U.A.

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2024-12-30 Sale	2025-01-02 4:15 pm	NewAmsterdam Pharma Co N.V.	NAMS	ForGrowth NAP B.V. Forbion Capital Fund IV Cooperatief U.A. Forbion IV Management B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner	29,846	$25.54	$762,174	10,656,172 (Indirect)	View
2024-12-26 Sale	2024-12-30 4:15 pm	NewAmsterdam Pharma Co N.V.	NAMS	ForGrowth NAP B.V. Forbion Capital Fund IV Cooperatief U.A. Forbion IV Management B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner	74,910	$25.98	$1,945,918	10,686,018 (Indirect)	View
2024-12-20 Sale	2024-12-26 4:15 pm	NewAmsterdam Pharma Co N.V.	NAMS	ForGrowth NAP B.V. Forbion Capital Fund IV Cooperatief U.A. Forbion IV Management B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner	91,068	$25.58	$2,329,520	10,760,928 (Indirect)	View
2024-12-18 Sale	2024-12-20 4:25 pm	NewAmsterdam Pharma Co N.V.	NAMS	ForGrowth NAP B.V. Forbion Capital Fund IV Cooperatief U.A. Forbion IV Management B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner	157,234	$25.86	$4,066,714	10,851,996 (Indirect)	View
2024-12-16 Sale	2024-12-18 4:15 pm	NewAmsterdam Pharma Co N.V.	NAMS	ForGrowth NAP B.V. Forbion Capital Fund IV Cooperatief U.A. Forbion IV Management B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner	115,480	$25.95	$2,996,156	11,009,230 (Indirect)	View
2024-12-12 Sale	2024-12-16 4:15 pm	NewAmsterdam Pharma Co N.V.	NAMS	ForGrowth NAP B.V. Forbion Capital Fund IV Cooperatief U.A. Forbion IV Management B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner	191,762	$25.34	$4,859,875	11,124,710 (Indirect)	View
2024-12-10 Sale	2024-12-12 4:15 pm	NewAmsterdam Pharma Co N.V.	NAMS	ForGrowth NAP B.V. Forbion Capital Fund IV Cooperatief U.A. Forbion IV Management B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner	462,288	$25.4	$11,740,618	11,316,472 (Indirect)	View
2024-11-15 Sale	2024-11-19 4:15 pm	NewAmsterdam Pharma Co N.V.	NAMS	ForGrowth NAP B.V. Forbion Capital Fund IV Cooperatief U.A. Forbion IV Management B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner	41,803	$25.07	$1,047,876	11,778,760 (Indirect)	View
2024-11-13 Sale	2024-11-15 4:36 pm	NewAmsterdam Pharma Co N.V.	NAMS	ForGrowth NAP B.V. Forbion Capital Fund IV Cooperatief U.A. Forbion IV Management B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner	10,898	$25.01	$272,511	11,820,563 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
Ownership	2024-01-02 4:00 pm	N/A N/A	NewAmsterdam Pharma Co N.V.	NAMS	ForGrowth NAP B.V. Forbion Capital Fund IV Cooperatief U.A. Forbion IV Management B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner	0	$0	11,831,461 (Indirect)	View
2020-09-21 Conversion	2020-09-23 7:06 pm	N/A N/A	Dyne Therapeutics Inc.	DYN	Forbion Capital Fund IV Cooperatief U.A. 10% Owner	26,467,258	$0	6,131,079 (Direct)	View
Ownership	2020-09-16 8:44 pm	N/A N/A	Dyne Therapeutics Inc.	DYN	Forbion Capital Fund IV Cooperatief U.A. 10% Owner	0	$0	6,131,079 (Direct)	View

Insider Trading & Ownership - Forbion Capital Fund IV Cooperatief U.A.